In this present study, CXCL9 and CXCL10 were found to be up-regulated in RA compared with both OA and normal controls which provided evidence for the previous study and suggested that they might be potential biomarkers for discrimination of RA and OA. Here, CXCL10 is linked to rheumatoid arthritis.